QLT Inc (NASDAQ:QLTI)
| 7.93 Data as of May 21 |  +0.08 / +1.02%Today’s Change | 6.33 Today|||52-Week Range 9.10 | +0.89% Year-to-Date |
Latest QLTI News | Press Releases
| QLTI July Options Begin Trading May 20 / TheStreet.com | QLT Is Now Oversold (QLTI) May 17 / TheStreet.com |
Today’s Trading
| Previous close | 7.85 |
| Today’s open | 7.83 |
| Day’s range | -- - -- |
| Volume | 56,228 |
| Average volume (3 months) | 112,938 |
| Market cap | $396.7M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/21/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +45.80% |
| Earnings growth (next 5 years) | +74.60% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 1.04 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SGMOSangamo BioSciences ... | -0.02 | -0.25% |
| AMRIAlbany Molecular Res... | -0.29 | -2.59% |
| SGYPSynergy Pharmaceutic... | -0.23 | -4.43% |
| DYAXDyax Corp | 0.00 | 0.00% |
Data as of 4:00pm ET, 05/21/2013
Financials
| Next reporting date | July 30, 2013 |
| EPS forecast (this quarter) | -$0.11 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | $45.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Financial Officer Sukhi Jagpal, MBA |
Senior Vice President- Development Suzanne M. Cadden |
Corporate headquarters Vancouver, British Columbia |
Forecasts
